Nuvasive NVM5 EMG Module, REF 8020015, Rx ONLY, CE2797, Nonsterile, UDI: 00887517206633 - Produc...

FDA Device Recall #Z-2684-2020 — Class II — June 10, 2020

Recall Summary

Recall Number Z-2684-2020
Classification Class II — Moderate risk
Date Initiated June 10, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm NuVasive Inc
Location San Diego, CA
Product Type Devices
Quantity 23

Product Description

Nuvasive NVM5 EMG Module, REF 8020015, Rx ONLY, CE2797, Nonsterile, UDI: 00887517206633 - Product Usage: is intended for intraoperative neurophysiologic monitoring during spinal surgery.

Reason for Recall

The NVM5 EMG Module kit intended for intraoperative neurophysiologic monitoring during spinal surgery contains incorrect component, part number 1715945, SSEP harness instead of the the correct part number 1747065, NVM5 Harness, Gen 3.5 EM. This issue can result in delay in therapy or lack of EMG neuromonitoring during surgery if the surgeon elects to proceed without the NVM5.

Distribution Pattern

US Nationwide distribution including in the states of AR, CA, IA, IL, WI. OUS: None

Lot / Code Information

Lot 1075097

Other Recalls from NuVasive Inc

Recall # Classification Product Date
Z-0738-2023 Class II X-CORE 2 Ti Core, Static. Part of the NuVasive... Nov 10, 2022
Z-1052-2023 Class III NuVasive MD Pulse III Multimodality System REF ... Jul 19, 2022
Z-1453-2022 Class II Description/Part: Simplify Disc Size 1, Ht 5/... Jun 20, 2022
Z-1898-2020 Class II NUVASIVE MAGEC 2 Rod X.X mm XX mm, REF MC2-XXXX... Feb 13, 2020
Z-0361-2013 Class II 7.5mm x 30mm Cannulated Screw Shank Subseque... Jan 5, 2009

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.